No menu items!

Brazil health regulator authorizes sale of two cannabis-based products

RIO DE JANEIRO, BRAZIL - Used for medical treatments, these products differ from the 5 others already approved in that they are composed of plant extracts, i.e., they have a set of substances extracted from the plant in their composition, unlike others composed of isolated cannabidiol.

Both are prepared from ethanolic extracts of the aerial parts of cannabis sativa and manufactured in Switzerland. They will be imported and distributed in Brazil as ready-to-use finished products.

"Plant extracts have a complex composition and can contain many active substances, which act through different mechanisms in the human body, making the . . .

To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed?

Check out our other content